A Study to Evaluate the Efficacy of the Valsartan/Simvastatin Combinations 160/20mg up Titrated to 320/20mg Versus 160/40mg up Titrated to 320/40mg in Patients With Both Essential Hypertension and Hypercholesterolemia.
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Simvastatin (Primary) ; Valsartan (Primary)
- Indications Essential hypertension; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Novartis
- 18 Jan 2006 New trial record.